Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase.

Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature. 1992 Jul 02; 358(6381):70-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.